Form 4: Executive Chairman Glazek Boosts TPB Holdings

Turning Point Brands' Executive Chairman David Glazek reported significant equity transactions, including RSU settlements and a revised financing agreement.

Summary

• David Edward Glazek, Executive Chairman and Director of Turning Point Brands, Inc. (TPB), reported multiple equity transactions.
• On March 2, 2026, Glazek acquired 28,921 shares, 4,412 shares, and 1,663 shares of common stock, respectively, from the settlement of performance restricted units granted in May 2023, March 2024, and March 2025, as performance criteria were met. Each acquisition was at a price of $108.51 per share.
• On the same date, 2,075 shares were disposed of at $108.51 to cover tax obligations related to the settled performance restricted stock units.
• On March 3, 2026, Glazek received a grant of 4,535 restricted stock units under the company's 2021 Equity Incentive Plan at a price of $107.57 per unit.
• Following these transactions, Glazek beneficially owns 164,539 shares of common stock, which includes 40,491 restricted stock units and 124,048 common shares, with 60,364 shares deferred into a Non-Qualified Deferred Plan.
• Glazek also holds options to acquire 54,289 shares at an exercise price of $27.19 (expiring 03/11/2034) and 47,519 shares at $20.71 (expiring 05/12/2033), both granted under the 2021 Equity Incentive Plan.
• A previously disclosed financing transaction from June 4, 2025, was revised on December 19, 2025, with an unaffiliated dealer. Glazek received approximately $7.0 million and pledged up to 78,000 shares of TPB common stock.
• The revised financing has a maturity date of December 19, 2027, obligating Glazek to repay in cash or deliver up to 78,000 shares at a price ranging from $105.33 to $126.39, based on the market price at maturity. The revised financing was completed at a price per share of $110.87.
• Glazek retains beneficial ownership, including dividend and voting rights, of the pledged shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive. While there's a disposition for taxes and a personal financing arrangement involving pledged shares, the core transactions reflect the successful vesting of performance-based equity and new RSU grants, indicating management's continued alignment and achievement of performance targets.

Positives

• Performance criteria for restricted stock units granted in May 2023, March 2024, and March 2025 were met, leading to the settlement and issuance of common stock.
• David Glazek received a new grant of 4,535 restricted stock units, indicating continued incentive alignment with the company's performance.
• Glazek retains beneficial ownership, including dividend and voting rights, of the 78,000 shares pledged in the revised financing transaction.

Negatives

• 2,075 shares were disposed of to cover tax obligations related to the settlement of performance restricted stock units, reducing the net shares acquired.
• The revised financing transaction involves pledging up to 78,000 shares of the issuer's common stock, which could be subject to market price fluctuations affecting the repayment obligation.
• The forward contract obligates the reporting person to repay a lender in cash or deliver shares, introducing a potential future liability tied to the stock price.

Risks

• Market Price Volatility: The obligation to repay the financing transaction in cash or deliver shares at a price ranging from $105.33 to $126.39 by December 19, 2027, exposes the reporting person to market price fluctuations of TPB common stock. If the stock price falls below the lower end of the range, the cash repayment obligation could be higher than the value of the pledged shares, or delivering shares could result in a loss.
• Concentration Risk: Pledging a significant number of shares (up to 78,000) as collateral for a personal financing transaction represents a concentration of risk for the individual, although the filing states beneficial ownership is retained.

Future Outlook

The filing indicates future obligations for the reporting person related to a financing transaction maturing on December 19, 2027, where repayment will be in cash or shares based on future market prices. Additionally, outstanding stock options have expiration dates extending to 2033 and 2034, and restricted stock units will settle in accordance with their terms.

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 are routine disclosures providing transparency into executive and director holdings. While this specific filing details personal equity movements and a financing arrangement for David Glazek, it does not directly reflect broader industry trends. However, the continued grant of equity incentives and the meeting of performance criteria for RSUs suggest ongoing efforts by Turning Point Brands to align executive compensation with company performance, a common practice across industries.

Comparison to Industry Standards

• N/A. This Form 4 filing details individual insider transactions and a personal financing arrangement, which are not typically compared to industry-wide benchmarks or specific competitor projects. The equity incentive plan itself is a standard corporate governance tool, but the specifics of an individual's holdings and financing are unique to the reporting person.

Stakeholder Impact

• Shareholders: The increase in beneficial ownership by a key executive (net of tax-related dispositions) can be seen as a positive signal of management's confidence and alignment with shareholder interests. The pledging of shares for a personal financing transaction introduces a minor, indirect risk related to potential future share sales if the obligation cannot be met otherwise, but beneficial ownership is retained.
• Employees: The continued use of the 2021 Equity Incentive Plan for RSU grants demonstrates the company's commitment to performance-based compensation, which can motivate employees.

Next Steps

• Repayment of the revised financing transaction by December 19, 2027, either in cash or by delivering up to 78,000 shares.
• Settlement of the 4,535 restricted stock units granted on March 3, 2026, in accordance with the 2021 Equity Incentive Plan.
• Exercise of outstanding stock options with expiration dates in 2033 and 2034, if deemed beneficial.
• Settlement of 60,364 deferred common shares from the Non-Qualified Deferred Plan according to its terms.

Key Dates

Recommendation

This Form 4 filing primarily details routine executive compensation events, including the vesting of performance-based restricted stock units and a new RSU grant, alongside a personal financing arrangement. While the increase in beneficial ownership by the Executive Chairman is generally positive, the transactions are largely expected and do not introduce new material information that would significantly alter the investment thesis for Turning Point Brands. The personal financing arrangement, while involving pledged shares, is a personal liquidity event for the executive and does not directly reflect on the company's operational or financial performance. Therefore, a 'hold' recommendation is appropriate as the filing does not present compelling reasons for a 'buy' or 'sell' action based solely on this information.

Keywords

Turning Point Brands, TPB, David Glazek, Form 4, Insider Trading, Equity Incentive Plan, Restricted Stock Units, RSU, Stock Options, Performance Units, Executive Compensation, Financing Transaction, Pledged Shares, Corporate Governance